LEADER 03340nam 2200877z- 450 001 9910557205303321 005 20231214133546.0 035 $a(CKB)5400000000041887 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/76280 035 $a(EXLCZ)995400000000041887 100 $a20202201d2021 |y 0 101 0 $aeng 135 $aurmn|---annan 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aFungal Infections Complicating COVID-19 210 $aBasel, Switzerland$cMDPI - Multidisciplinary Digital Publishing Institute$d2021 215 $a1 electronic resource (98 p.) 311 $a3-0365-0554-7 311 $a3-0365-0555-5 330 $aCoronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread globally to pandemic proportions. Although the majority of cases have asymptomatic or mild infections, a significant proportion of cases progress to severe pneumonia and acute respiratory distress syndrome requiring critical care. Opportunistic infections following severe respiratory viral infections have been recognized since the 1918 influenza pandemic. Among critically ill patients with COVID-19, secondary fungal infections caused by Aspergillus and Candida spp. are increasingly described, affecting up to 30% of COVID-19 patients requiring intensive care treatment. This collection of manuscripts focuses on fungal infections complicating COVID-19, including immunological mechanisms and pathogenesis, diagnosis, and treatment. 606 $aMedicine$2bicssc 610 $aSARS-CoV-2 610 $aco-infection 610 $apulmonary aspergillosis 610 $aICU 610 $aazole-resistant Aspergillus 610 $aAspergillus fumigatus 610 $aCAPA 610 $aTR34L98H 610 $aSARS COV-2 610 $aAspergillus 610 $anovel coronavirus 610 $asuperinfection 610 $arisk factors 610 $aprevalence 610 $achallenges 610 $aimmune response 610 $aexpert statement 610 $aEuropean Confederation of Medical Mycology 610 $aCOVID-19 610 $afungaemia 610 $aSaccharomyces 610 $aco-infections 610 $ainvasive aspergillosis 610 $aputative 610 $aprobable 610 $aSars-CoV-2 610 $aPCR 610 $agalactomannan 610 $aclassification 610 $aCOVID-19 pneumonia 610 $ainvasive pulmonary aspergillosis 610 $adiagnosis 610 $amulti-triazole resistance 610 $aCOVID-19 associated invasive pulmonary aspergillosis 610 $acoinfection 610 $adiabetes 610 $abloodstream infection 610 $aCandida glabrata 610 $aechinocandin resistance 610 $aFKS mutation 610 $acandidemia 610 $acandiduria 610 $aoral candidiasis 610 $amycobiome 615 7$aMedicine 700 $aHoenigl$b Martin$4edt$01287896 702 $aTalento$b Alida Fe$4edt 702 $aHoenigl$b Martin$4oth 702 $aTalento$b Alida Fe$4oth 906 $aBOOK 912 $a9910557205303321 996 $aFungal Infections Complicating COVID-19$93036854 997 $aUNINA